Paolocci Nazareno, Jackson Matthew I, Lopez Brenda E, Miranda Katrina, Tocchetti Carlo G, Wink David A, Hobbs Adrian J, Fukuto Jon M
Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
Pharmacol Ther. 2007 Feb;113(2):442-58. doi: 10.1016/j.pharmthera.2006.11.002. Epub 2006 Nov 29.
Nitroxyl (HNO), the 1-electron reduced and protonated congener of nitric oxide (NO), has received recent attention as a potential pharmacological agent for the treatment of heart failure and as a preconditioning agent for the mitigation of ischemia-reperfusion injury. Interest in the pharmacology and biology of HNO has prompted examination, or in some instances reexamination, of many of its chemical properties. Such studies have provided insight into the chemical basis for the biological effects of HNO, although the biochemical mechanisms for many of these effects remain to be established. In this review, a brief description of the biologically relevant chemistry of HNO is given, followed by a more detailed discussion of the pharmacology and potential toxicology of HNO.
硝酰(HNO)是一氧化氮(NO)单电子还原并质子化后的类似物,最近作为治疗心力衰竭的潜在药物以及减轻缺血再灌注损伤的预处理剂受到关注。对HNO药理学和生物学的兴趣促使人们对其许多化学性质进行研究,在某些情况下是重新研究。这些研究为HNO生物学效应的化学基础提供了见解,尽管其中许多效应的生化机制仍有待确定。在本综述中,首先简要描述了与HNO生物学相关的化学性质,随后更详细地讨论了HNO的药理学和潜在毒理学。